Skip to main content

Table 1 Baseline clinical characteristics

From: Gender differences in plaque characteristics of nonculprit lesions in patients with coronary artery disease

Variable

Men, n = 77

Women, n = 26

P Value

 Age, y

60.8 ± 9.8

70.8 ± 7.3

< 0.001

Risk factors

 Hypertension, n (%)

47 (61.4)

13 (50.0)

0.324

 Dyslipidemia, n (%)

39 (50.6)

15 (57.7)

0.534

 Diabetes mellitus, n (%)

31 (40.3)

10 (38.5)

0.871

 Current smoker, n (%)

23 (29.9)

1 (3.8)

0.007

Medications before admission

 Aspirin, n (%)

63 (81.8)

22 (84.6)

0.745

 Statins, n (%)

57 (74.0)

21 (80.8)

0.488

 β-Blockers, n (%)

29 (37.7)

10 (38.5)

0.942

 ACE inhibitors, n (%)

19 (24.7)

7 (26.9)

0.820

Biochemistry data

 TC, mg/dL

151.6 ± 37.5

166.6 ± 37.5

0.082

 LDL-C, mg/dL

79.4 ± 27.6

92.2 ± 27.0

0.043

 HDL-C, mg/dL

40.2 ± 7.6

43.1 ± 12.6

0.164

 TG, mg/dL

178.4 ± 167.7

149.9 ± 65.2

0.402

 HbA1c, %

6.6 ± 1.3

6.9 ± 1.5

0.415

 hs-CRP, mg/L

3.0 ± 2.8

1.6 ± 1.3

0.082

 Creatinine, mg/L

0.9 ± 0.2

0.8 ± 0.2

0.018

 Fasting glucose, mg/L

116.1 ± 41.8

139.1 ± 68.0

0.113

  1. Abbreviations: HbA1c glycated hemoglobin, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, IQR interquartile range, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, TG triglycerides. Data are n (%) or mean ± SD